← All stocks

INSMED Inc

INSM Net selling
CIK 0001104506 #651 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$3.74M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$3.74M
2 of 2 sales
Net
−$3.74M
−$3.74M against sales at will

By person

15 insiders · 2 transactions
71.5×

William H. Lewis holds 71.5 times base salary in stock. $61.13M of shares against $854.55K in salary for 2025.

Salary from the company's own proxy. The shares are what William H. Lewis last reported holding, valued at $124.00, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Brennan David R
Director
$3.10M (1)
−$3.10M
159,238
0.0729%
$19.75M
−12.4%
SHAROKY MELVIN MD
Director
$637.65K (1)
−$637.65K
246,081
0.1127%
$30.51M
−20.9%
Lewis William
Chair and CEO
492,982
0.2257%
$61.13M
−1.3%
Wise John Drayton
Chief Commercial Officer
133,015
0.0609%
$16.49M
+8.6%
Adsett Roger
Chief Operating Officer
98,744
0.0452%
$12.24M
−34.4%
MCGIRR DAVID W J
Director
97,723
0.0447%
$12.12M
−1.2%
Desjardins Clarissa
Director
73,337
0.0336%
$9.09M
+18.4%
Bonstein Sara
Chief Financial Officer
69,082
0.0316%
$8.57M
−41.7%
SCHAFER CAROL
Director
66,622
0.0305%
$8.26M
+14.4%
ANDERSON ELIZABETH M
Director
62,034
0.0284%
$7.69M
−9.7%
Flammer Martina M.D.
Chief Medical Officer
60,486
0.0277%
$7.50M
−43.0%
LEE LEO
Director
57,971
0.0265%
$7.19M
−53.5%
Schaeffer Orlov S Nicole
Chief People Strategy Officer
41,754
0.0191%
$5.18M
−58.4%
Smith Michael Alexander
Chief Legal Officer
37,648
0.0172%
$4.67M
−44.9%
Butera Samuele
SVP, GM, Global Respiratory
7,342
0.0034%
$910.41K
Insider
Date
Role
Action
Shares
Price
Amount
Brennan David R
9 Sep 2026
Director
Sell
25,000
$124.00
$3.10M
SHAROKY MELVIN MD
17 Aug 2026
Director
Sell indirect
5,000
$127.53
$637.65K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 4 Oct 2016